Literature DB >> 26664035

Estimating the Tradeoff Between Risk Protection and Moral Hazard with a Nonlinear Budget Set Model of Health Insurance.

Amanda E Kowalski1.   

Abstract

Insurance induces a tradeoff between the welfare gains from risk protection and the welfare losses from moral hazard. Empirical work traditionally estimates each side of the tradeoff separately, potentially yielding mutually inconsistent results. I develop a nonlinear budget set model of health insurance that allows for both simultaneously. Nonlinearities in the budget set arise from deductibles, coinsurance rates, and stoplosses that alter moral hazard as well as risk protection. I illustrate the properties of my model by estimating it using data on employer sponsored health insurance from a large firm.

Entities:  

Keywords:  health insurance; moral hazard; nonlinear budget set; risk protection

Year:  2015        PMID: 26664035      PMCID: PMC4671305          DOI: 10.1016/j.ijindorg.2015.08.001

Source DB:  PubMed          Journal:  Int J Ind Organ        ISSN: 0167-7187


  18 in total

1.  The economics of moral hazard revisited.

Authors:  J A Nyman
Journal:  J Health Econ       Date:  1999-12       Impact factor: 3.883

2.  Asymmetric information in health insurance: evidence from the National Medical Expenditure Survey.

Authors:  J H Cardon; I Hendel
Journal:  Rand J Econ       Date:  2001

3.  The effect of wages, taxes and fixed costs on women's labor force participation.

Authors:  J A Hausman
Journal:  J Public Econ       Date:  1980-10

4.  Health insurance: the tradeoff between risk pooling and moral hazard.

Authors:  W G Manning; M S Marquis
Journal:  J Health Econ       Date:  1996-10       Impact factor: 3.883

5.  The demand for episodes of treatment in the Health Insurance Experiment.

Authors:  E B Keeler; J E Rolph
Journal:  J Health Econ       Date:  1988-12       Impact factor: 3.883

6.  A new estimate of the welfare loss of excess health insurance.

Authors:  R Feldman; B Dowd
Journal:  Am Econ Rev       Date:  1991-03

7.  Beyond Testing: Empirical Models of Insurance Markets.

Authors:  Liran Einav; Amy Finkelstein; Jonathan Levin
Journal:  Annu Rev Econom       Date:  2010

8.  Balancing the goals of health care provision and financing.

Authors:  Martin Feldstein
Journal:  Health Aff (Millwood)       Date:  2006 Nov-Dec       Impact factor: 6.301

9.  Health insurance and the demand for medical care: evidence from a randomized experiment.

Authors:  W G Manning; J P Newhouse; N Duan; E B Keeler; A Leibowitz; M S Marquis
Journal:  Am Econ Rev       Date:  1987-06

10.  ESTIMATING WELFARE IN INSURANCE MARKETS USING VARIATION IN PRICES.

Authors:  Liran Einav; Amy Finkelstein; Mark R Cullen
Journal:  Q J Econ       Date:  2010-08-01
View more
  7 in total

1.  The RAND Health Insurance Experiment, three decades later.

Authors:  Aviva Aron-Dine; Liran Einav; Amy Finkelstein
Journal:  J Econ Perspect       Date:  2013

2.  Imperfect risk adjustment, risk preferences, and sorting in competitive health insurance markets.

Authors:  Timothy J Layton
Journal:  J Health Econ       Date:  2017-12       Impact factor: 3.883

3.  THE RESPONSE OF DRUG EXPENDITURE TO NON-LINEAR CONTRACT DESIGN: EVIDENCE FROM MEDICARE PART D.

Authors:  Liran Einav; Amy Finkelstein; Paul Schrimpf
Journal:  Q J Econ       Date:  2015-02-08

4.  MORAL HAZARD IN HEALTH INSURANCE: DO DYNAMIC INCENTIVES MATTER?

Authors:  Aviva Aron-Dine; Liran Einav; Amy Finkelstein; Mark Cullen
Journal:  Rev Econ Stat       Date:  2015-10

5.  When Should There Be Vertical Choice in Health Insurance Markets?

Authors:  Victoria R Marone; Adrienne Sabety
Journal:  Am Econ Rev       Date:  2022-01

6.  Risk Protection, Service Use, and Health Outcomes under Colombia's Health Insurance Program for the Poor.

Authors:  Grant Miller; Diana Pinto; Marcos Vera-Hernández
Journal:  Am Econ J Appl Econ       Date:  2013-10

7.  The moral hazard effects of consumer responses to targeted cost-sharing.

Authors:  Christopher M Whaley; Chaoran Guo; Timothy T Brown
Journal:  J Health Econ       Date:  2017-10-12       Impact factor: 3.883

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.